
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.8B | $3.8B | $4B | $3.9B | |
Revenue Growth (YoY) | -13.48% | 8.83% | 35.45% | 5.27% | -2.23% | |
Cost of Revenues | $2.3B | $2.5B | $3.4B | $3.5B | $3.3B | |
Gross Profit | $245M | $254M | $368M | $487M | $531M | |
Gross Profit Margin | 9.62% | 9.16% | 9.8% | 12.32% | 13.74% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $193M | $175M | $188M | $207M | $207M | |
Other Inc / (Exp) | -$61M | $10M | $5M | -$16M | -$28M | |
Operating Expenses | $193M | $175M | $188M | $207M | $207M | |
Operating Income | $52M | $79M | $180M | $280M | $324M | |
Net Interest Expenses | $11M | $8M | $10M | $7M | -- | |
EBT. Incl. Unusual Items | -$20M | $81M | $175M | $257M | $298M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $28M | $31M | $45M | -$248M | $14M | |
Net Income to Company | -$48M | $50M | $130M | $505M | $284M | |
Minority Interest in Earnings | -$8M | -$9M | -$6M | -$19M | -$10M | |
Net Income to Common Excl Extra Items | -$56M | $41M | $124M | $486M | $274M | |
Basic EPS (Cont. Ops) | -$2.01 | $1.46 | $4.41 | $17.30 | $9.93 | |
Diluted EPS (Cont. Ops) | -$2.01 | $1.44 | $4.35 | $17.05 | $9.82 | |
Weighted Average Basic Share | $27.9M | $28M | $28.1M | $28.1M | $27.6M | |
Weighted Average Diluted Share | $27.9M | $28.4M | $28.5M | $28.5M | $27.9M | |
EBITDA | $100M | $199M | $297M | $378M | $409M | |
EBIT | -$4M | $91M | $189M | $274M | $313M | |
Revenue (Reported) | $2.5B | $2.8B | $3.8B | $4B | $3.9B | |
Operating Income (Reported) | $52M | $79M | $180M | $280M | $324M | |
Operating Income (Adjusted) | -$4M | $91M | $189M | $274M | $313M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $746M | $818M | $967M | $933M | $934M | |
Revenue Growth (YoY) | 16.02% | 9.65% | 18.22% | -3.52% | 0.11% | |
Cost of Revenues | $673M | $742M | $857M | $814M | $796M | |
Gross Profit | $73M | $76M | $110M | $119M | $138M | |
Gross Profit Margin | 9.79% | 9.29% | 11.38% | 12.76% | 14.78% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $45M | $44M | $52M | $52M | $47M | |
Other Inc / (Exp) | $5M | $1M | -$3M | -$4M | $3M | |
Operating Expenses | $45M | $44M | $52M | $52M | $47M | |
Operating Income | $28M | $32M | $58M | $67M | $91M | |
Net Interest Expenses | $2M | $2M | $3M | -- | -- | |
EBT. Incl. Unusual Items | $31M | $31M | $52M | $63M | $95M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12M | $8M | $14M | $19M | $28M | |
Net Income to Company | $19M | $23M | $38M | $44M | $67M | |
Minority Interest in Earnings | -$3M | -$1M | -$4M | -$2M | -$2M | |
Net Income to Common Excl Extra Items | $16M | $22M | $34M | $42M | $65M | |
Basic EPS (Cont. Ops) | $0.57 | $0.79 | $1.21 | $1.52 | $2.39 | |
Diluted EPS (Cont. Ops) | $0.56 | $0.77 | $1.18 | $1.50 | $2.36 | |
Weighted Average Basic Share | $27.9M | $28M | $28.2M | $27.6M | $27.2M | |
Weighted Average Diluted Share | $28.4M | $28.4M | $28.7M | $28M | $27.5M | |
EBITDA | $61M | $61M | $86M | $89M | $123M | |
EBIT | $34M | $34M | $57M | $67M | $98M | |
Revenue (Reported) | $746M | $818M | $967M | $933M | $934M | |
Operating Income (Reported) | $28M | $32M | $58M | $67M | $91M | |
Operating Income (Adjusted) | $34M | $34M | $57M | $67M | $98M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.7B | $2.8B | $3.9B | $3.9B | $3.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.4B | $2.6B | $3.5B | $3.4B | $3.3B | |
Gross Profit | $265M | $257M | $402M | $496M | $550M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $184M | $174M | $196M | $207M | $202M | |
Other Inc / (Exp) | -$27M | $6M | $1M | -$17M | -$21M | |
Operating Expenses | $184M | $174M | $196M | $207M | $202M | |
Operating Income | $81M | $83M | $206M | $289M | $348M | |
Net Interest Expenses | $11M | $8M | $11M | $4M | -- | |
EBT. Incl. Unusual Items | $42M | $81M | $196M | $268M | $330M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $35M | $27M | $51M | -$243M | $23M | |
Net Income to Company | $7M | $54M | $145M | $511M | $307M | |
Minority Interest in Earnings | -$12M | -$7M | -$9M | -$17M | -$10M | |
Net Income to Common Excl Extra Items | -$5M | $47M | $136M | $494M | $297M | |
Basic EPS (Cont. Ops) | -$0.18 | $1.68 | $4.84 | $17.62 | $10.81 | |
Diluted EPS (Cont. Ops) | -$0.21 | $1.65 | $4.75 | $17.37 | $10.67 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $164M | $199M | $322M | $381M | $443M | |
EBIT | $58M | $91M | $212M | $284M | $344M | |
Revenue (Reported) | $2.7B | $2.8B | $3.9B | $3.9B | $3.9B | |
Operating Income (Reported) | $81M | $83M | $206M | $289M | $348M | |
Operating Income (Adjusted) | $58M | $91M | $212M | $284M | $344M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $746M | $818M | $967M | $933M | $934M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $673M | $742M | $857M | $814M | $796M | |
Gross Profit | $73M | $76M | $110M | $119M | $138M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $45M | $44M | $52M | $52M | $47M | |
Other Inc / (Exp) | $5M | $1M | -$3M | -$4M | $3M | |
Operating Expenses | $45M | $44M | $52M | $52M | $47M | |
Operating Income | $28M | $32M | $58M | $67M | $91M | |
Net Interest Expenses | $2M | $2M | $3M | -- | -- | |
EBT. Incl. Unusual Items | $31M | $31M | $52M | $63M | $95M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12M | $8M | $14M | $19M | $28M | |
Net Income to Company | $19M | $23M | $38M | $44M | $67M | |
Minority Interest in Earnings | -$3M | -$1M | -$4M | -$2M | -$2M | |
Net Income to Common Excl Extra Items | $16M | $22M | $34M | $42M | $65M | |
Basic EPS (Cont. Ops) | $0.57 | $0.79 | $1.21 | $1.52 | $2.39 | |
Diluted EPS (Cont. Ops) | $0.56 | $0.77 | $1.18 | $1.50 | $2.36 | |
Weighted Average Basic Share | $27.9M | $28M | $28.2M | $27.6M | $27.2M | |
Weighted Average Diluted Share | $28.4M | $28.4M | $28.7M | $28M | $27.5M | |
EBITDA | $61M | $61M | $86M | $89M | $123M | |
EBIT | $34M | $34M | $57M | $67M | $98M | |
Revenue (Reported) | $746M | $818M | $967M | $933M | $934M | |
Operating Income (Reported) | $28M | $32M | $58M | $67M | $91M | |
Operating Income (Adjusted) | $34M | $34M | $57M | $67M | $98M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $496M | $452M | $520M | $515M | $623M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $484M | $549M | $672M | $666M | $578M | |
Inventory | $177M | $262M | $348M | $298M | $283M | |
Prepaid Expenses | $18M | $21M | $18M | $24M | $23M | |
Other Current Assets | $11M | $12M | $10M | $4M | $5M | |
Total Current Assets | $1.3B | $1.4B | $1.7B | $1.6B | $1.6B | |
Property Plant And Equipment | $608M | $527M | $488M | $527M | $552M | |
Long-Term Investments | $60M | $54M | $49M | $35M | $27M | |
Goodwill | $49M | $50M | $45M | $44M | $81M | |
Other Intangibles | $78M | $68M | $54M | $46M | $71M | |
Other Long-Term Assets | $19M | $14M | $21M | $21M | $34M | |
Total Assets | $2.3B | $2.2B | $2.5B | $2.7B | $2.9B | |
Accounts Payable | $500M | $522M | $657M | $551M | $505M | |
Accrued Expenses | $52M | $30M | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | $4M | $13M | $18M | $18M | |
Current Portion Of Capital Lease Obligations | $32M | $28M | $29M | $30M | $29M | |
Other Current Liabilities | $30M | $67M | $75M | $78M | $81M | |
Total Current Liabilities | $824M | $852M | $1B | $931M | $916M | |
Long-Term Debt | $349M | $349M | $336M | $318M | $301M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.8B | $1.6B | $1.7B | $1.6B | $1.6B | |
Common Stock | $1M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | -$304M | -$229M | -$213M | -$254M | -$306M | |
Common Equity | $387M | $516M | $675M | $1B | $1.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $123M | $100M | $99M | $85M | $81M | |
Total Equity | $510M | $616M | $774M | $1.1B | $1.3B | |
Total Liabilities and Equity | $2.3B | $2.2B | $2.5B | $2.7B | $2.9B | |
Cash and Short Terms | $496M | $452M | $520M | $515M | $623M | |
Total Debt | $349M | $353M | $349M | $336M | $319M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $482M | $402M | $484M | $504M | $655M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $466M | $539M | $695M | $652M | $613M | |
Inventory | $188M | $331M | $358M | $342M | $310M | |
Prepaid Expenses | $26M | $29M | $25M | $22M | $26M | |
Other Current Assets | $10M | $8M | $4M | $3M | $7M | |
Total Current Assets | $1.3B | $1.5B | $1.7B | $1.6B | $1.7B | |
Property Plant And Equipment | $576M | $507M | $492M | $535M | $590M | |
Long-Term Investments | $57M | $58M | $44M | $30M | $29M | |
Goodwill | $48M | $50M | $46M | $44M | $80M | |
Other Intangibles | $75M | $66M | $49M | $43M | $73M | |
Other Long-Term Assets | $18M | $17M | $30M | $27M | $34M | |
Total Assets | $2.2B | $2.2B | $2.4B | $2.7B | $3B | |
Accounts Payable | $486M | $539M | $605M | $566M | $556M | |
Accrued Expenses | $52M | $31M | $32M | $48M | -- | |
Current Portion Of Long-Term Debt | -- | -- | $21M | $18M | $18M | |
Current Portion Of Capital Lease Obligations | $31M | $28M | $30M | $31M | $22M | |
Other Current Liabilities | $84M | $71M | $75M | $81M | $81M | |
Total Current Liabilities | $775M | $849M | $964M | $938M | $927M | |
Long-Term Debt | $349M | $349M | $331M | $314M | $297M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B | |
Common Stock | $1M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | -$321M | -$225M | -$197M | -$268M | -$287M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $122M | $101M | $87M | $85M | $84M | |
Total Equity | $506M | $642M | $807M | $1.1B | $1.4B | |
Total Liabilities and Equity | $2.2B | $2.2B | $2.4B | $2.7B | $3B | |
Cash and Short Terms | $482M | $402M | $484M | $504M | $655M | |
Total Debt | $349M | $349M | $352M | $332M | $315M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$48M | $50M | $130M | $505M | $284M | |
Depreciation & Amoritzation | $104M | $108M | $108M | $104M | $96M | |
Stock-Based Compensation | $18M | $18M | $26M | $34M | $41M | |
Change in Accounts Receivable | $51M | -$78M | -$156M | $13M | $61M | |
Change in Inventories | -$2M | -$92M | -$105M | $52M | $1M | |
Cash From Operations | $168M | $58M | $167M | $267M | $427M | |
Capital Expenditures | $104M | $70M | $81M | $125M | $137M | |
Cash Acquisitions | -$2M | -$5M | -- | -- | -$55M | |
Cash From Investing | -$98M | -$63M | -$68M | -$123M | -$189M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $400M | -- | $350M | -- | -- | |
Long-Term Debt Repaid | -$400M | -- | -$350M | -$13M | -$18M | |
Repurchase of Common Stock | -$16M | -- | -- | -$106M | -$63M | |
Other Financing Activities | -$5M | -$33M | -$5M | -$45M | -$19M | |
Cash From Financing | -$58M | -$29M | -$9M | -$156M | -$100M | |
Beginning Cash (CF) | $469M | $500M | $455M | $523M | $518M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $12M | -$34M | $90M | -$12M | $138M | |
Ending Cash (CF) | $500M | $455M | $523M | $518M | $626M | |
Levered Free Cash Flow | $64M | -$12M | $86M | $142M | $290M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$11M | $23M | $23M | $75M | -- | |
Depreciation & Amoritzation | $28M | $25M | $26M | $24M | -- | |
Stock-Based Compensation | $5M | $8M | $9M | $11M | -- | |
Change in Accounts Receivable | $47M | -$80M | $6M | -$52M | -- | |
Change in Inventories | -$18M | $9M | $22M | $28M | -- | |
Cash From Operations | -$10M | -$51M | $61M | $57M | -- | |
Capital Expenditures | $15M | $15M | $30M | $31M | -- | |
Cash Acquisitions | -$2M | -- | -- | -- | -- | |
Cash From Investing | -$16M | -$10M | -$29M | -$35M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$4M | -$5M | -- | |
Repurchase of Common Stock | -- | -- | -$30M | -- | -- | |
Other Financing Activities | -- | -- | -$22M | -- | -- | |
Cash From Financing | $6M | -- | -$52M | -$5M | -- | |
Beginning Cash (CF) | $486M | $405M | $487M | $507M | -- | |
Foreign Exchange Rate Adjustment | $4M | -$19M | -$8M | -$16M | -- | |
Additions / Reductions | -$20M | -$61M | -$20M | $17M | -- | |
Ending Cash (CF) | $470M | $325M | $459M | $508M | -- | |
Levered Free Cash Flow | -$25M | -$66M | $31M | $26M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7M | $54M | $145M | $511M | $307M | |
Depreciation & Amoritzation | $106M | $108M | $110M | $97M | $99M | |
Stock-Based Compensation | $17M | $19M | $29M | $36M | $42M | |
Change in Accounts Receivable | -$47M | -$76M | -$175M | $29M | $34M | |
Change in Inventories | -$3M | -$146M | -$39M | $6M | $32M | |
Cash From Operations | $154M | $26M | $169M | $355M | $428M | |
Capital Expenditures | $78M | $73M | $81M | $141M | $135M | |
Cash Acquisitions | -$2M | -$6M | $1M | -- | -$55M | |
Cash From Investing | -$72M | -$69M | -$67M | -$140M | -$185M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$350M | -$17M | -$18M | |
Repurchase of Common Stock | -- | -- | -- | -$126M | -$50M | |
Other Financing Activities | -- | -- | -- | -$44M | -$22M | |
Cash From Financing | -$435M | -$33M | -$10M | -$182M | -$87M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$353M | -$76M | $92M | $33M | $156M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $76M | -$47M | $88M | $214M | $293M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8M | $46M | $61M | $119M | $67M | |
Depreciation & Amoritzation | $55M | $52M | $55M | $46M | $25M | |
Stock-Based Compensation | $9M | $13M | $17M | $21M | $11M | |
Change in Accounts Receivable | $51M | -$74M | -$7M | -$49M | -$24M | |
Change in Inventories | -$35M | -$62M | $17M | -$23M | -$20M | |
Cash From Operations | $1M | -$72M | $42M | $126M | $70M | |
Capital Expenditures | $33M | $36M | $51M | $68M | $35M | |
Cash Acquisitions | -$2M | -$1M | -- | -- | -- | |
Cash From Investing | -$31M | -$31M | -$49M | -$72M | -$33M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$4M | -$9M | -$4M | |
Repurchase of Common Stock | -- | -- | -$30M | -$20M | -$7M | |
Other Financing Activities | -- | -- | -$30M | -$7M | -$10M | |
Cash From Financing | $6M | -$4M | -$57M | -$36M | -$18M | |
Beginning Cash (CF) | $986M | $860M | $1B | $1B | $626M | |
Foreign Exchange Rate Adjustment | -$6M | -$23M | -- | -$28M | $13M | |
Additions / Reductions | -$24M | -$107M | -$64M | $18M | $19M | |
Ending Cash (CF) | $956M | $730M | $946M | $1B | $658M | |
Levered Free Cash Flow | -$32M | -$108M | -$9M | $58M | $35M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.